Bill 122: Health Services and Insurance Act (amended)

This bill primarily affects pharmacists and healthcare providers in Nova Scotia who administer vaccines — think community pharmacies and family medicine clinics that routinely give the Shingrix two-dose series. Currently, patients pay out of pocket (often $300–$400 total) or rely on private insurance, so publicly covering this vaccine would shift billing to MSI rather than patients or private insurers. Pharmacies and clinics would need to update their billing processes to submit Shingrix administration claims through MSI. Private insurers who currently cover Shingrix for some clients may see reduced claims volume. The change affects providers of all sizes, from a solo pharmacist to a larger multi-location pharmacy chain.